Afexa Life Sciences, Inc.
Afexa Life Sciences, Inc. is a health-sciences and technology company. It engages in the development and commercialization of naturally derived, evidence-based, health products for disease prevention and health maintenance in the United States and Canada. The company develops, commercializes and patents a proprietary technology, known as ChemBioPrint, which is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded in 1992 and is headquartered in Edmonton, Canada.